GAPDH and cancer: Recently Tan et al. [65], showed that FK866 treatment of cancer cells led to an attenuation of glycolysis at the GAPDH reaction resulting in a carbon overflow into the pentose phosphate pathway, a reduced carbon flow into the TCA cycle, and eventually a reduction in cellular ATP.